Recombinant Fowlpox-TRICOM Vaccine
A vaccine comprised of a recombinant fowlpox virus vector encoding a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM), which may enhance antigen presentation and activate cytotoxic T-cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. (NCI04) [ ]
Term info
Recombinant Fowlpox-TRICOM Vaccine
- Recombinant Fowlpox-TRICOM
- Recombinant Fowlpox-TRICOM Vaccine
- rF-TRICOM
- rF-TRICOM (B7.1.iCAM1-LFA3-Fowlpox)
- recombinant fowlpox-TRICOM vaccine
NCIT_C116978, NCIT_C128784, NCIT_C116977
A cancer vaccine made with a form of a chicken virus that does not cause disease in humans. It is being studied in the treatment of some types of cancer. The virus is changed in the laboratory to make human proteins that may help immune cells in the body kill tumor cells.
CTRP
Recombinant Fowlpox-TRICOM Vaccine
Fowlpox-TRICOM_Vaccine
710658
38543
Recombinant Fowlpox-TRICOM Vaccine
Virus, Pharmacologic Substance
C1134570
C2667
Term relations
- Fowlpox Virus Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Gene Regulation Process
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation